See also this year's filing and all EDGAR filings for this company.
PDF Report 0001671858_2022_ARS_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001671858')"} |
Graph
Absolute values for 0001671858, ARS Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 261,492,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,212,000 |
| 3 | remainder_Assets | 69,763,000 |
| 4 | LiabilitiesCurrent | 14,892,000 |
| 5 | LiabilitiesNoncurrent | 4,760,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 28,083,000 |
| 9 | ResearchAndDevelopmentExpense | 61,501,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 106,000 |
| 13 | remainder_ComprehensiveNetIncome | -326,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 333,467,000 |
| 1 | Liabilities | 19,652,000 |
| 2 | Expenses | 89,584,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 313,815,000 |
| 5 | NetIncome | -89,478,000 |
| 6 | ComprehensiveNetIncome | -89,641,000 |
| 7 | BaseVar | 221,567,500 |
| 8 | EconomicCapitalRatio | 2.55 |
Edgar->Model Mapping
Feature Distribution
Change over Time
